10.1016/j.virol.2004.09.033
World Health Organization. (2003). Severe Acute Respiratory Syndrome
(SARS) in Taiwan, China. Retrieved from
https://www.who.int/csr/don/2003_12_17/en/
World Health Organization. (2013). Novel coronavirus infection-update.
Retrieved from
https://www.who.int/csr/don/2012_11_30/en/
Wu, X., Liu, H., Xiao, H., Kim, J., Seshaiah, P., Natsoulis, G., Boeke,
J. D., Hahn, B. H., and Kappes, J. C. (1995). Targeting foreign proteins
to human immunodeficiency virus particles via fusion with Vpr and Vpx.
Journal Of Virology, 69, 3389-3398.
Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L.,
Du, L., and Liu, S. (2020). Inhibition of SARS-CoV-2 infection
(previously 2019-nCoV) by a highly potent pan-coronavirus fusion
inhibitor targeting its spike protein that harbors a high capacity to
mediate membrane fusion. Cell Research, 30, 343-355. doi:10.1038/s41422-020-0305-x
Xu, Z., Peng, C., Shi, Y., Zhu, Z., Mu, K., Wang, X., and Zhu, W.
(2020). Nelfinavir was predicted to be a potential inhibitor of
2019-nCov main protease by an integrative approach combining homology
modelling, molecular docking and binding free energy calculation:
BioRxiv, Preprint. doi: 10.1101/2020.01.27.921627
Yamauchi, Y. and Greber, U. F. (2016). Principles of virus uncoating:
cues and the snooker ball. Traffic, 17, 569-592. doi: